Louis M. Staudt
Louis Staudt defined the molecular subtypes of large B-cell lymphoma that guide targeted therapy.
Discovered the germinal-centre and activated B-cell subtypes of DLBCL and the chronic active BCR signalling that made BTK inhibitors work in lymphoma; directs NCI's cancer genomics centre.
| Title | Journal | Year |
|---|---|---|
| Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Nature | 2000 |
| Genetics and pathogenesis of diffuse large B-cell lymphoma | New England Journal of Medicine | 2018 |
Pages like this
not linked directly; found by shared links- PersonBrigitte C. Widemann
Shares NCI Center for Cancer Research (intramural programme), National Cancer Institute (NIH).
- PersonJames L. Gulley
Shares NCI Center for Cancer Research (intramural programme), National Cancer Institute (NIH).
- PersonRaffit Hassan
Shares NCI Center for Cancer Research (intramural programme), National Cancer Institute (NIH).
- PersonNirali N. Shah
Shares NCI Center for Cancer Research (intramural programme), National Cancer Institute (NIH).
- IdeaPet dogs with spontaneous cancer as a bridge before human trials
Shares National Cancer Institute (NIH), Diffuse large B-cell lymphoma.
- PersonDouglas R. Lowy
Shares NCI Center for Cancer Research (intramural programme), National Cancer Institute (NIH).
- PersonSteven A. Rosenberg
Shares NCI Center for Cancer Research (intramural programme), National Cancer Institute (NIH).
- InstitutionFrederick National Laboratory for Cancer Research
Shares NCI Center for Cancer Research (intramural programme), National Cancer Institute (NIH).